Former MMA champion, UFC fighter and Olympic wrestler Ben Askren has received a double lung transplant during a weekslong hospital stay for severe pneumonia, according to his wife, Amy.

New research uncovers how smoking triggers DNA mutations in lung cells—insights that could help scientists develop better cancer prevention strategies. (CREDIT: Thinkstock) ...

Three years ago, before I learned that I had metastatic cancer, doctors repeatedly told me I was “too young” to be seriously ill.

The U.S. Food and Drug Administration said on Wednesday it has approved Nuvation Bio's drug for patients with a rare and aggressive form of lung cancer.

The U.S. FDA has approved treatment with Ibtrozi for patients with locally advanced or metastatic ROS1-positive non-small cell lung cancer.

New research has identified the mechanism by which air pollution damages the lungs’ self-cleaning system, leaving us vulnerable to infection. In doing so, it has also identified a way to reverse ...

Insilico Medicine A drug developed using artificial intelligence showed signs of efficacy in treating an incurable lung disease in what its developer calls a clinical first.

Transpire Bio has licensed an inhaled PDE4 inhibitor from China’s Intragrand Pharma as a potential treatment for idiopathic pulmonary fibrosis.

Adding immunotherapy to chemotherapy before surgery for patients with operable non-small cell lung cancer—the leading cause of cancer deaths worldwide—improved long-term survival overall compared with ...

Pancreatic cancer spreads to liver or lung thanks to this protein Date: June 3, 2025 Source: University of California - San Francisco Summary: Scientists have discovered how pancreatic cancer ...

Neoadjuvant nivolumab plus chemotherapy significantly improved pathological complete response and event-free survival in patients with resectable non–small-cell lung cancer (NSCLC) in a phase 3 ...

Summit Therapeutics said its closely tracked antibody, the first lung cancer drug to beat Merck’s Keytruda in a head-to-head study, produced mixed results in a new trial.